Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-06-20

FDA Approved: GLYBURIDE-METFORMIN HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA notes a supplemental application for glyburide/metformin hydrochloride (Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc.) to update the labeling for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide-Metformin Hydrochloride (glyburide and metformin hydrochloride)

Snippet

SUPPL AP for GLYBURIDE-METFORMIN HYDROCHLORIDE (GLYBURIDE-METFORMIN HYDROCHLORIDE)